It has been reported that the abnormal expression of EBI3 is closely related to the poor prognosis of many malignant tumors, such as lung cancer [11], colon cancer [12], and nasopharyngeal cancer [10], and EBI3 plays different roles in different tumors. Here, EBI3 is linked to nasopharyngeal carcinoma.